---

Bill Title: To amend the Federal Food, Drug, and Cosmetic Act to provide for the development and use of patient experience data to enhance the structured risk-benefit assessment framework, and for other purposes.

Sponsorship: Partisan Bill (Republican 1)

Status: (Introduced - Dead) 2015-05-15 - Referred to the Subcommittee on Health. [HB2338 Detail]

Download: US_Congress-2015-HB2338-Introduced.pdf

---